← Eichor
Study identifier: NCT05780177 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Brief Behavioral Treatment for Insomnia in Veterans With Posttraumatic Stress Disorder

Condition: Posttraumatic Stress Disorder · Insomnia Disorder  ·  Sponsor: VA Office of Research and Development

PhaseNA
Planned participants200
Who can joinAll sexes, 18 Years to 75 Years
Healthy volunteersYes

About this study

This study will investigate treatments for insomnia in Veterans who have posttraumatic stress disorder (PTSD). The purpose of this study is to compare a brief behavioral treatment for insomnia (BBTI) to a treatment that helps promote relaxation (progressive muscle relaxation training or PMRT). The investigators will examine improvements in psychosocial functioning and insomnia severity. The investigators will also examine whether treatment gains last over time and whether suicidal ideation decreases following insomnia treatment.

This description comes directly from the study's public registry record.

Talk to the study team

Shira Maguen, PhD  ·  (415) 221-4810  ·  shira.maguen@va.gov

Joy Huggins, MA  ·  (415) 221-4810  ·  Joy.Huggins@va.gov

Always discuss trial participation with your own doctor first.

Locations (1)

San Francisco VA Medical Center, San Francisco, CASan Francisco, California, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05780177